🇺🇸 FDA
Patent

US 7659081

Determination of AM-binding proteins and the association of adrenomedullin (AM) therewith

granted A61KA61K2039/505A61K38/1709

Quick answer

US patent 7659081 (Determination of AM-binding proteins and the association of adrenomedullin (AM) therewith) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Feb 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary of the Department of Health and Human Services
Grant date
Tue Feb 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K2039/505, A61K38/1709, A61P, A61P43/00